Natalizumab as an Efficacy Switch in Participants With Relapsing Multiple Sclerosis After Failure on Other Therapies
Clinical trial NCT02241785 · TERMINATED
Trial details
- NCT number
- NCT02241785
- Sponsor
- Biogen
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-30
- Primary completion
- 2016-05-02
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.